Skip to content

Serratus Plane Block for the Prevention of Chronic Pain After Breast Cancer Surgery

Serratus Plane Block for the Prevention of Chronic Pain After Breast Cancer Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02838173
Enrollment
110
Registered
2016-07-20
Start date
2016-07-31
Completion date
2018-03-31
Last updated
2016-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast/Surgery, Chronic Pain, Postoperative Complication

Brief summary

This study compare the Serratus block plane (SPB) and the local infiltration of the tissue in the prevention of acute and chronic pain after breast cancer surgery.

Detailed description

Chronic pain after breast surgery may be severe, often requiring the use of morphine. The incidence of chronic pain varies from 27 to 50% depending on definitions. The infiltration of tissues by a local anesthetic is a simple, fast and low risk technique but of limited effectiveness. Serratus the flat block, performed under ultrasound guidance, is minimally invasive and easy to perform. It allows anesthesia and analgesia to an extended part of the anterolateral chest wall and the axilla. This regional anesthesia technique provides good analgesia during and after breast surgery, but remains to be evaluated; beyond perioperative analgesia, the benefit-risk, post operative rehabilitation, and the impact on ambulatory and on chronic pain are fundamental objectives.

Interventions

PROCEDUREserratus plane bloc : Ropivacaine 2mg/ml (0,3ml/kg)
PROCEDUREtissue infiltration : Ropivacaine 2mg/ml (0,3ml/kg)
PROCEDUREserratus plane bloc : placebo
PROCEDUREtissue infiltration : placebo

Sponsors

Erasme University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women scheduled for elective breast neoplasm surgery * Of ASA classification 1, 2 or 3 * Patients who provide written informed consent

Exclusion criteria

* Minor patients * Patients refusing to sign the consent * Patients included in another protocol within 3 months * Pregnant or lactating patients * Patients with history of allergy to local anesthetics (Ropivacaine) * Patients with contraindication to regional anesthesia (coagulopathy, local infection ...) * Patients with history of prior breast surgery (excluding diagnostic biopsy) * Patients with history of chronic pain * Patients with a history of psychiatric disorder

Design outcomes

Primary

MeasureTime frameDescription
postoperative chronic pain assessed using the DN4 questionnaire3 months postoperativeDN4 questionnaire

Secondary

MeasureTime frameDescription
postoperative acute painday 1, day 2, day 3 postoperativeVisual analogue scale (V.A.S.)
morphine consumptionday 1, day 2, day 3 postoperative

Other

MeasureTime frame
length of stay in the Postoperative Acute Care Unitthrough study completion
length of stay in hospitalthrough study completion

Contacts

Primary ContactCéline Boudart, MD
cboudart@ulb.ac.be3225553919
Backup ContactWendy Villareal Fernandez, MD

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026